ClinicalThought

Share

Program Content

Activities

  • Call to Action: TROP2 ADCs in Lung Cancer
    Call to Action: Misperceptions on TROP2-Targeted Antibody–Drug Conjugates in Lung Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 24, 2023

    Expires: February 23, 2024

  • TROP2 ADC + IO in NSCLC
    Combination Therapy With TROP2-Targeted Antibody–Drug Conjugates and Immunotherapy in Advanced/Metastatic NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 03, 2023

  • TROP2 ADCs for NSCLC 2023
    Progress in the Development of Antibody–Drug Conjugates Targeting TROP-2 for Advanced NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 19, 2023

Provided by

ProCE Banner

Supporters

AstraZeneca

Daiichi Sankyo, Inc.

Gilead Sciences, Inc.